Why is Welcure Drugs falling/rising?

As of 10-Oct, Welcure Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 7.67, with a change of 0.36, representing a rise of 4.92%. The stock has shown strong performance recently, gaining 39.45% over the last seven days and outperforming its sector by 3.69% today. However, it is important to note that the stock has a mixed performance over longer periods, with a decline of 21.49% over the past month and a year-to-date drop of 34.28%. Additionally, while the stock is currently above its 5-day and 20-day moving averages, it remains below its longer-term moving averages, indicating potential volatility. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader Market Context: In comparison to the benchmark Sensex, which has increased by 1.59% over the past week, Welcure Drugs has significantly outperformed with a return of 27.20%. This short-term performance highlights a strong rebound relative to the broader market. However, the stock's year-to-date performance remains concerning, as it has underperformed the Sensex, which has gained 5.58% during the same period. The falling investor participation, indicated by a significant drop in delivery volume, may suggest caution among investors despite the recent price increase.